2017

Multidonor intensive fecal microbiota transplantation in UC

Once- Versus Twice-daily Mesalazine to Induce Remission in Paediatric Ulcerative Colitis: A Randomised Controlled Trial

Effect of no-carrageenan diet in UC activity

CT-P13 or infliximab originator in immune mediated inflammatory diseases

Tofacitinib in UC

Efficacy and safety of golimumab 52-week maintenance therapy in Japanese patients with moderate to severely active ulcerative colitis: a phase 3, double-blind, randomized, placebo-controlled study-(PURSUIT-J study)

Phase 2 trial Risankizumab in Crohn’s disease

Topical tacrolimus in UC proctitis

PF-00547659 in UC

Tofacitinib for induction and maintenance therapy of Crohn’s disease: results of two phase IIb randomised placebo-controlled trials